Alvotech Files Higher-Strength Adalimumab In US And EU

Rival To Humira 100mg/ml To Be Marketed By Teva And Stada Respectively

 
• By David Wallace
  
Close up of EU and US flag
Alvotech has filed its 100mg/ml biosimilar version of Humira in the US and EU • Source: Shutterstock

More from Biosimilars

More from Products